01302.HK
LifeTech Scientific Corporation
HKSE · Healthcare · Medical - Devices · CN
HKD 1.32
−4.00%Year over year
Reported trailing growth
- Revenue
- -3.2%
- EBITDA
- +105.9%
- EBIT
- +164.3%
- EPS
- -22.9%
- Free cash flow
- -16.1%
- Operating cash flow
- -12.9%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +7.7%
- EBITDA
- -13.2%
- EBIT
- -21.1%
- Net income
- -23.1%
- EPS
- -24.6%
- Free cash flow
- +111.7%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026